Enveric Biosciences Inc vs Harmony Gold Mining Co. — how do they compare? Enveric Biosciences Inc trades at $1.41 (market cap $5.32M), while Harmony Gold Mining Co. trades at $14.87 (market cap $9.38B). The key difference: Harmony Gold Mining Co. is far larger — about 1763.2× Enveric Biosciences Inc's market cap, and Harmony Gold Mining Co. pays a 2.69% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | HMY | |
|---|---|---|
Market Cap | $5.32M | $9.38B |
Sector | Health | Basic Materials |
52-Week High | $17.40 | $26.04 |
52-Week Low | $1.28 | $12.61 |
Enterprise Value | $408.82K | $9.72B |
Dividend Yield | — | 2.69% |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Harmony Gold Mining (HMY) trades at $15.24, up 1.67% today, with bearish technical signals from moving averages. The company shows strong fundamentals with 2024 revenue of $61.38B and net income of $8.59B, delivering a 20.06% net margin. Recent earnings show mixed results with a Q4 2025 miss but previous quarters beating expectations. The stock offers a dividend yield with a $0.31 payment scheduled for May 2026.
HMY presents value with attractive valuation ratios (P/E 9.69, EV/EBITDA 5.04) and robust profitability (ROE 32.32%). However, analyst sentiment is cautious with 70% hold ratings, and technical indicators suggest near-term pressure. Key risks include gold price volatility and Federal Reserve policy impacts, while the transition to gold-copper hybrid operations offers long-term growth potential.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
Read more on HMY →